Testing effectiveness (Phase 2)Active Not RecruitingNCT04881032
What this trial is testing
AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
Who this might be right for
Glioblastoma
Centre Jean Perrin 66